Our mission

Eliminating epidemic meningitis in sub-Saharan Africa

The Meningitis Vaccine Project (MVP) is a partnership between PATH and the World Health Organization.

The mission of MVP is to eliminate meningitis as a public health problem in sub-Saharan Africa through the development, testing, introduction, and widespread use of conjugate meningococcal vaccines.

Our objectives are:

‘Once such an initiative is accepted by all the countries, and a commitment is made, epidemic meningitis will be a thing of the past.’

Prof. Francis Nkrumah, Chair of MVP's Project Advisory Group

  • To develop meningococcal conjugate vaccines that are appropriate for use in Africa.
  • To monitor the effectiveness and safety of the vaccines in controlled clinical trials.
  • To create pathways for the licensure of vaccines.
  • To assure production in sufficient volume at a price that facilitates wide use in Africa.
  • To investigate innovative ways to finance the procurement of vaccines through local, country, and other global programs.
  • To introduce the vaccines through mass and routine immunization in synergy with other public health programs.